Interv Akut Kardiol. 2002;1(2):85-89

Chronic regurgitative valve disease of left heart yesterday and today

Roman Čerbák
Centrum kardiovaskulární a transplantační chirurgie v Brně

Diagnosis and treatment of mitral and aortic regurgitation have recently undergone significant improvements. Understanding of the pathophysiologic changes of volume and pressure preload of the left heart chamber in valve regurgitation have contributed to the understanding of the crucial differences between aortic and mitral regurgitation. Detailed information about left heart chamber function has offered earlier surgical solutions to these disorders. Preoperative diagnosis consists mainly of noninvasive evaluations, surgical intervention favouring valve repair operations. Advances in cardiosurgery, anaesthesia and postoperative care have brought improvement, both in the surgical outcomes and the long term quality of life of a patient.

Keywords: chronic mitral regurgitation, chronic aortic regurgitation, function of left heart chamber, indications for operation, cardiosurgery of valve diseases.

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čerbák R. Chronic regurgitative valve disease of left heart yesterday and today. Interv Akut Kardiol. 2002;1(2):85-89.
Download citation

References

  1. Štětka F, Čerbák R, Černý J, Dominik J, Ničovský J, Útrata P. Chronická mitrální regurgitace: kdy indikovat k operaci? Vnitřní lék.1988;34:362-367.
  2. Loogen F, Bostroem B, Gleichmann U, Kreuzer H. Forum cardiologicum 12. Aortenstenose und Aorteninsuffizienz. Boehringer Mannheim 1969.
  3. Cardiovascular Disease in Europe. Euro Heart Survey. European Society of Cardiology Sophia Antipolis 2002.
  4. Carabello BA. Progress in Mitral and Aortic Regurgitation. Progress in Cardiovasc Dis 2001;43:457-475. Go to original source... Go to PubMed...
  5. Kaul S, Spotnitz WD, Glasheen WP, et al. Mechanism of ischemic mitral regurgitation. An experimental evaluation. Circulation 1991;84:2167-2180. Go to original source... Go to PubMed...
  6. Spinale FG, Ishihara K, Zile M, et al. Structural basis for changes in left ventricular function and geometry because of chronic mitral regurgitation and after correction of volume overload. J Thorac Cardiovasc Surg 1993;106:1147-1157. Go to original source...
  7. Imamura T, McDermott PJ, Kent RL, et al. Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload. Circ Res 1994;75:418-425. Go to original source... Go to PubMed...
  8. Matsuo T, Carabello BA, Nagatomo Y, et al. Mechanism of cardiac hypertrophy in canine volume overload. Am J Physiol 1998;275:65-74. Go to original source... Go to PubMed...
  9. Scholte WJM. National Society March Days. Newsletter 2002;11:5.
  10. Niederle P, et al. Echokardiografie. Triton Praha 2002.
  11. Čerbák R, Pokorný P, Štětka F, et al. Chronická aortální regurgitace s dysfunkcí levé komory: indikace k operaci? CorVasa 2001;43:17-22.
  12. Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994;331:689-694. Go to original source... Go to PubMed...
  13. Frídl P, Marek T, Čerbák R. et al. Doporučené postupy pro diagnostiku a léčbu nemocných s chlopenní vadou v dospělosti. CorVasa 2000;42:K82-K86.
  14. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. JACC 1998;32:1486-1588.
  15. Dominik J. Kardiochirurgie. Grada Publishing Praha 1998.




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.